![]() |
![]() |
Legal status
Patent in force
(51) | INT.CL. | A61K 31/401 | (2006.01) |
A61K 31/506 | (2006.01) | ||
A61K 45/06 | (2006.01) | ||
A61K 31/4422 | (2006.01) | ||
A61K 31/513 | (2006.01) | ||
A61K 31/549 | (2006.01) | ||
A61P 9/12 | (2006.01) | ||
A61K 31/41 | (2006.01) |
(11) | Number of the document | 3658140 |
(13) | Kind of document | T |
(96) | European patent application number | 17794712.4 |
Date of filing the European patent application | 2017-11-06 | |
(97) | Date of publication of the European application | 2020-06-03 |
(45) | Date of publication and mention of the grant of the patent | 2025-05-21 |
(46) | Date of publication of the claims translation | 2025-08-25 |
(86) | Number | PCT/EP2017/078371 |
Date | 2017-11-06 |
(87) | Number | WO 2018/153513 |
Date | 2018-08-30 |
(30) | Number | Date | Country code |
PCT/EP2017/054489 | 2017-02-27 | WO | |
PCT/EP2017/061487 | 2017-05-12 | WO |
(72) |
BELLET, Marc , CH
BOLLI, Martin , CH
CLOZEL, Martine , CH
IGLARZ, Marc , CH
KOHLER, Philipp , CH
SCHINDELHOLZ, Ivan , CH
VON RAUMER, Markus , CH
|
(73) |
Idorsia Pharmaceuticals Ltd ,
Hegenheimermattweg 91, 4123 Allschwil,
CH
|
(74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
(54) | Aprocitentano ir kitų veikliųjų sudedamųjų dalių deriniai, skirti atsparios hipertenzijos gydymui |
COMBINATIONS OF APROCITENTAN WITH FURTHER ACTIVE INGREDIENTS FOR THE TREATMENT OF RESISTANT HYPERTENSION |